Your session is about to expire
← Back to Search
Mirikizumab Solution (Reference) for Healthy Subjects
Study Summary
This trial evaluates how well a drug is tolerated & how much gets into the bloodstream when given via syringe. Adverse effects & duration of 17 wks incl. 35 day screening are also evaluated.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Logistics
Participation is compensated
You will be compensated for participating in this trial.
Who is running the clinical trial?
Frequently Asked Questions
Does this research study accommodate individuals aged 25 and above?
"According to the trial's eligibility criteria, the lower limit of enrollment is 18 and no adult over 65 should apply."
What safety precautions should be taken when utilizing Mirikizumab Solution (Reference)?
"There is limited safety and efficacy data for Mirikizumab Solution (Reference), warranting a rating of 1 on the scale."
How widely distributed are the locales where this experiment is taking place in town?
"At present, the trial is running at 6 different medical facilities. These locations are situated in Miami, Cypress and Dallas as well as other nearby cities. It may be beneficial to opt for a centre close by so that you can reduce any travel requirements should you choose to participate."
Is this research project still accommodating participants?
"Unfortunately, the clinical trial does not appear to be enrolling patients at this time according to information available on clinicaltrials.gov; it was originally posted in December 2022 and most recently updated a month ago. However, 838 other trials are currently recruiting new participants."
Could I qualify to join this experiment?
"This clinical trial is recruiting 410 individuals aged between 18 and 65 years old who present as generally healthy (hs). Furthermore, participants must have a BMI between of 18.0 to 34.0 kg/m2, with only males or non-pregnant women of childbearing potential accepted for enrolment."
Who else is applying?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
What state do they live in?
Share this study with friends
Copy Link
Messenger